about
Rapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3ηIdentification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patientsAnxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior.Mechanisms underlying the antidepressant response and treatment resistance.Stem cell therapy: a new approach to the treatment of refractory depression.Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats.Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanismSerotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.Rodent models of treatment-resistant depression.Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.GABAergic control of depression-related brain statesPeripheral biomarkers in animal models of major depressive disorder.A method for biomarker measurements in peripheral blood mononuclear cells isolated from anxious and depressed mice: β-arrestin 1 protein levels in depression and treatment.Global state measures of the dentate gyrus gene expression system predict antidepressant-sensitive behaviors.5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function.Learned helplessness and social avoidance in the Wistar-Kyoto rat.Towards translational rodent models of depression.Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression.The failure of the antidepressant drug discovery process is systemic.The role of 5-HT receptors in depression.Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depressionExploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression I: bio-behavioural validation and response to imipramine.Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression.Utility of the Berlin questionnaire for predicting obstructive sleep apnea in individuals with treatment-resistant depression.
P2860
Q28652455-1032C2BF-D6FD-48E1-99B7-E1C691B56BDDQ30511886-EE29416D-0875-4A60-A20C-40603BCF014AQ30534769-371E7832-C64C-4794-A49B-061A1B9626B6Q33814386-625BEFFC-572F-462E-912C-5FCB652B36E3Q34215946-04463C69-109A-4A2C-9A86-6187804A3A3BQ34273681-D2977D2F-4D92-4D3D-A478-8FB5DBDF1404Q34657940-26409E78-F5D8-4E97-93E5-D7C1F8D265AAQ34666955-0956025C-1C29-4E93-ACA0-D2C1078E5A45Q35580361-1C651EB4-941E-4F0E-B00F-60C12C524E72Q36648936-41D909AA-BE7E-4723-919B-AAE022455598Q36668325-7686E4AC-2B5F-4606-8E84-8E14D3EED906Q37176590-A2680A77-B93C-4F09-9DC7-72FF33D218F6Q37199234-E57C162A-4D1B-4481-B812-444D6C735B64Q37490660-87DADB97-B47B-48DD-99EA-D830E5BB055CQ37591142-E1294899-4D54-4C03-B106-2F1B9FCA65A6Q37689549-AC5A669A-B8BB-41FB-97E0-2F11B528D379Q38092709-14626595-3236-457A-BD2D-37C301217952Q38634678-39118E00-052A-40ED-AF6C-D51ADB34B753Q39202075-9E992A4E-B040-4C11-9991-488B12C92351Q39395776-8828B933-690F-46A9-A50E-F6F57A451363Q41107282-E167E46F-B31C-4139-82E7-F915761B7703Q48043296-15B622DD-B8CE-4D66-90A2-6956FD62DA31Q48075957-4EF94920-0855-4D47-9F4C-2AB54051F0CBQ48183889-956DBA9E-E055-4D6E-8C93-06E3B688AA43
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Modeling treatment-resistant depression.
@ast
Modeling treatment-resistant depression.
@en
type
label
Modeling treatment-resistant depression.
@ast
Modeling treatment-resistant depression.
@en
prefLabel
Modeling treatment-resistant depression.
@ast
Modeling treatment-resistant depression.
@en
P2093
P2860
P1433
P1476
Modeling treatment-resistant depression
@en
P2093
Alain Michel Gardier
Amanda Williams
Benjamin Adam Samuels
Erik H F Wong
Reto Gadient
P2860
P304
P356
10.1016/J.NEUROPHARM.2011.02.017
P577
2011-02-26T00:00:00Z